Time Course and Predictors of Symptoms After Primary Prostate Cancer Therapy
Journal of Clinical Oncology2003Vol. 21(21), pp. 3979–3986
Citations Over TimeTop 10% of 2003 papers
James A. Talcott, Judith Manola, Jack A. Clark, Irving Kaplan, Clair J. Beard, S. P. Mitchell, Ronald C. Chen, Michael P. O’Leary, Philip W. Kantoff, Anthony V. D’Amico
Abstract
Pretreatment function and the primary treatment modality for early stage PC strongly predict the affected organ systems and time course of dysfunction. With this information, patients and their physicians may refine their choice of treatment and better anticipate its consequences.
Related Papers
- Prevalence of antidepressant-associated erectile dysfunction.(2003)
- → Sexual dysfunction and depression: Etiology, prevalence, and treatment(2001)55 cited
- → Sexual Dysfunction in Essential Hypertension: Myth or Reality?(2006)55 cited
- Prevalence of Antidepressant-Associated Erectile Dysfunction(2003)
- → Lifestyle/Dietary Recommendations for Erectile Dysfunction and Female Sexual Dysfunction(2011)28 cited